4752 Federal Register / Vol. 74, No. 16 / Tuesday, January 27, 2009 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): Autism 

Therapy Evaluation Effects of 

Hyperbaric Oxygen Therapy on 

Children with Autism, Request For 

Application (RFA), DD8EM–801. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1:30 p.m.–3 p.m., 

January 29, 2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the review, discussion, and 

evaluation of an application received in 

response to ‘‘Autism Therapy 

Evaluation Effects of Hyperbaric Oxygen 

Therapy on Children with Autism, RFA 

DD8EM–801.’’ 

This Federal Register notice is being 

published less than fifteen days prior to 

the meeting date, due to the decision of 

the National Center for Chronic Disease 

Prevention and Health Promotion to 

allow a deliberative discussion on this 

application. 

Contact Person for More Information: 

Brenda Colley Gilbert, Ph.D., Scientific 

Review Administrator, 2877 

Brandywine Road, Atlanta, Georgia 

30341, telephone: (770) 488–8390. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Lorenzo J. Falgiano, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–1690 Filed 1–26–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number NIOSH–144] 

Notice of Request for Public To Submit 

Comments; Extension of Comment 

Period 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Extension of public comment 

period. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announced the availability of a draft 

document available for public comment 

entitled ‘‘NIOSH Criteria Document 

Update: Occupational Exposure to 

Hexavalent Chromium’’ on October 17, 

2008, as well as a public meeting to be 

held on January 22, 2009. The document 

and instructions for submitting 

comments can be found at http:// 

www.cdc.gov/niosh/review/public/144/. 

Comments were to be provided to the 

NIOSH docket by January 31, 2009, as 

well as given orally at the public 

meeting. A request has been received to 

extend the comment period to permit 

the public more time to gather and 

submit information. 

Accordingly, NIOSH is extending the 

public comment period by 60 days to 

March 31, 2009. 

DATES: Written comments to NIOSH 

must be sent or postmarked by March 

31, 2009. The public meeting will still 

take place on January 22, 2009, at Robert 

A. Taft Laboratories, Taft Auditorium, 

NIOSH, CDC, 4676 Columbia Parkway, 

Cincinnati, OH 45226–1998. 

Status: The public meeting will 

include scientists and representatives 

from various government agencies, 

industry, labor, and other stakeholders, 

and is open to the public, limited only 

by the space available. The meeting 

room accommodates 80 people. Persons 

wanting to attend or provide oral 

comments at the meeting were 

requested to notify the NIOSH Docket 

Office no later than January 7, 2009, at 

(513) 533–8611 or by e-mail at 

nioshdocket@cdc.gov. 

Persons wanting to provide oral 

comments will be permitted up to 20 

minutes. If additional time becomes 

available, presenters will be notified. 

Oral comments given at the meeting 

must also be submitted to the docket in 

writing in order to be considered by the 

Agency. Written comments will also be 

accepted at the meeting. Written 

comments may also be submitted to the 

NIOSH Docket Office, Robert A. Taft 

Laboratories, 4676 Columbia Parkway, 

MS–C34, Cincinnati, Ohio 45226, 

telephone (513) 533–8611. All material 

submitted to the Agency should 

reference docket number NIOSH–144 

and must be submitted by March 31, 

2009, to be considered by the Agency. 

All electronic comments should be 

formatted as Microsoft Word. Please 

make reference to docket number 

NIOSH–144. 

All information received in response 

to this notice will be available for public 

examination and copying at the NIOSH 

Docket Office, Room 111, 4676 

Columbia Parkway, Cincinnati, Ohio 

45226. 

CONTACT PERSONS FOR TECHNICAL

INFORMATION: Kathleen MacMahon, 

DVM; (513) 533–8547; MS–C32, Robert 

A. Taft Laboratories, 4676 Columbia 

Parkway, Cincinnati, OH, 45226–1998. 

Dated: January 16, 2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–1694 Filed 1–26–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Pediatric Functional 

Neuroimaging Study. 

Date: January 29, 2009. 

mstockstill on PROD1PC66 with NOTICES6

Federal Register / Vol. 74, No. 16 / Tuesday, January 27, 2009 / Notices 4753 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Sathasiva B. Kandasamy, 

PhD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institute of Child Health and Human 

Development, 6100 Executive Boulevard, 

Room 5b01, Bethesda, MD 20892–9304, (301) 

435–6680, skandasa@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: January 16, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1662 Filed 1–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Mental Health Services Applications. 

Date: February 17, 2009. 

Time: 11:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW, Washington, DC 20036. 

Contact Person: Marina Broitman, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6153, MSC 9608, 

Bethesda, MD 20892–9608, 301–402–8152, 

mbroitman@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

NIMH K99 Review. 

Date: February 23, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW, Washington, DC 20036. 

Contact Person: Megan Libbey, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6148, MSC 9609, 

Bethesda, MD 20892–9609, 301–402–6807, 

libbeym@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Silvio O. Conte Centers for Basic and 

Translational Mental Health Research. 

Date: February 24–25, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW, Washington, DC 20036. 

Contact Person: Francois Boller, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

bollerf@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: January 16, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1653 Filed 1–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Ancillary Studies in 

Immunomodulation Clinical Trials. 

Date: February 17, 2009. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Paul A. Amstad, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

DHHS/National Institutes of Health/NIAID, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892–7616, 301–402–7098, 

pamstad@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 16, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1654 Filed 1–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; R13 Conference 

Application. 

Date: February 23, 2009. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

mstockstill on PROD1PC66 with NOTICES6